Q1 EPS Estimates for agilon health Decreased by Analyst

agilon health, inc. (NYSE:AGL) – Stock analysts at William Blair decreased their Q1 2025 earnings estimates for agilon health in a research report issued to clients and investors on Tuesday, February 25th. William Blair analyst R. Daniels now anticipates that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.05. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.08) EPS and Q4 2026 earnings at ($0.13) EPS.

Other research analysts have also issued research reports about the stock. TD Cowen dropped their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Macquarie started coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target for the company. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Wednesday. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Finally, Barclays dropped their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Down 9.4 %

Shares of AGL opened at $3.29 on Thursday. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $1.36 billion, a P/E ratio of -3.50 and a beta of 0.66. The company has a 50-day simple moving average of $2.91 and a 200-day simple moving average of $3.04.

Insider Activity

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John William Wulf purchased 45,000 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 77,500 shares of company stock valued at $169,600 over the last 90 days. 3.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Los Angeles Capital Management LLC bought a new stake in shares of agilon health during the third quarter worth approximately $513,000. Aigen Investment Management LP bought a new stake in shares of agilon health during the third quarter worth approximately $79,000. Simplify Asset Management Inc. raised its stake in shares of agilon health by 67.5% during the third quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock worth $663,000 after buying an additional 67,968 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of agilon health during the third quarter worth approximately $228,000. Finally, Citigroup Inc. grew its holdings in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.